Amit Chakrabarti
Overview
Explore the profile of Amit Chakrabarti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chakrabarti A, Chakrabarti A, Drexler Y, Swift S, Lash J, Kaplan R, et al.
Clin J Am Soc Nephrol
. 2025 Feb;
PMID: 40019804
No abstract available.
2.
Yadav A, Mukhopadhayay A, Chakrabarti A, Saha A, Bhattacharjee P
Indian J Occup Environ Med
. 2025 Jan;
28(4):304-312.
PMID: 39877273
Background: Chronic exposure to low-level environmental lead (Pb) causes several health effects in humans. Its biomonitoring by non-invasive biomarkers is imperative to identify Pb exposure in the occupationally unexposed general...
3.
Kalita M, M D, Saha I, Chakrabarti A
Indian J Med Res
. 2024 Dec;
160(5):397-406.
PMID: 39737507
Background & objectives Cancer is one of the leading causes of death among older adults worldwide. The global burden of cancer among older individuals is increasing due to the ageing...
4.
Das S, Sarkar S, Bhowmik K, Mukherjee S, Saha I, Basu A, et al.
Indian J Psychol Med
. 2024 Nov;
:02537176241259144.
PMID: 39564245
Objective: This study was performed to explore the perceptions of treatment utilization patterns and the risk of overdose of both opioid users and their peer educators in Kolkata, India. Methods:...
5.
Kalita M, Devaraja M, Saha I, Chakrabarti A
Indian J Med Res
. 2024 Nov;
160(2):165-175.
PMID: 39513212
Background & objectives Cancer contributes to decreasing life expectancy, especially in low- and middle- income countries (LMIC) and countries in transition where resources for diagnosis and care are limited. As...
6.
Majumder J, Saha I, Bagepally B, Kalita M, Munikrishnappa D, Ray S, et al.
Indian J Psychiatry
. 2024 Oct;
66(8):683-694.
PMID: 39398512
Background: Exposure to extreme weatherly events potentially develops mental disorders among affected individuals. Aim: To synthesize the burden of mental disorders following impact of extreme weather events in South-east Asian...
7.
Chakrabarti A, Saha I, Kalita M, Bhattacharya D, Haque B, Nagraj A, et al.
Indian J Med Res
. 2024 Oct;
160(1):95-101.
PMID: 39382493
Background & objectives Tobacco (30%), alcohol (21.4%) and cannabis (3%) are the three most commonly abused substances in India. Tobacco and alcohol abuse have higher prevalence rates among different occupational...
8.
Das S, Kalita M, Makhal M, Devaraja M, Bagepally B, Cherian J, et al.
BMC Psychiatry
. 2024 Oct;
24(1):663.
PMID: 39379847
Background: Pharmacogenomic (PGx) factors significantly influence how patients respond to antipsychotic medications This systematic review was performed to synthesize the clinical utility of PGx-assisted treatment versus standard of care in...
9.
Basu A, Dutta A, Bagepally B, Das S, Cherian J, Roy S, et al.
PLoS One
. 2024 Apr;
19(4):e0300511.
PMID: 38598465
Objectives: The response to antipsychotic therapy is highly variable. Pharmacogenomic (PGx) factors play a major role in deciding the effectiveness and safety of antipsychotic drugs. A hybrid type 2 effectiveness-implementation...
10.
Kashyap R, Holla B, Bhattacharjee S, Sharma E, Mehta U, Vaidya N, et al.
Psychol Med
. 2024 Mar;
54(10):2599-2611.
PMID: 38509831
Background: Several factors shape the neurodevelopmental trajectory. A key area of focus in neurodevelopmental research is to estimate the factors that have maximal influence on the brain and can tip...